Preventive medication adherence in African American and Caucasian headache patients

Headache

Volumn 51, Issue 4, 2011, Pages 520-532

  Heckman, Bernadette D ^a   Ellis, Gary ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Headache; Medication adherence; Race related health disparities

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; ERGOTAMINE; TRIPTAN DERIVATIVE;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; DISEASE SEVERITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MORBIDITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF CONCEPT;

ADULT; AFRICAN AMERICANS; ANALGESICS, NON-NARCOTIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEADACHE DISORDERS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 79953707338     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01866.x     Document Type: Article

References (58)

1. DiMatteo MR. Variations in patients' adherence to medication recommendations: A quantitative review of 50 years of research. Med Care. 2004;42:200-209.
2. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497. (Pubitemid 41127293)
3. Donnan PT, MacDonald TM, Morris AP. The DARTS/MEMO collaboration: Adherence to prescribed oral hypoglycemic medication in a population of patients with type two diabetes: A retrospective study. Diabetes Med. 2002;19:279-284. (Pubitemid 34592152)
4. Saran R, Bragg-Gresham JL, Rayner HC, et al. Non-adherence in hemodialysis: Association with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003;64:254-262.
5. Peterson LA, Wright SM, Person ED, et al. Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction. Med Care. 2002;40:186-196.
6. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiat Serv. 2004;55:886-891. (Pubitemid 39025215)
7. Ghali JK, Kadakia S, Cooper R, Ferlinez J. Precipitating factors leading to decompensated of heart failure:Traits among urban blacks. Arch Intern Med. 1988;148:2013-2016.
8. Dunbar-Jacob J, Mortimer-Stephens MK.Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54:S57-S60. (Pubitemid 34013691)
9. Levine AJ, Hinkin CH, Castellon SA, et al. Variation in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav. 2005;3:355-362. (Pubitemid 41584987)
10. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004;19:1096-1103. (Pubitemid 39552579)
11. Dunbar-Jacob J, Bohachick P, Mortimer MK, Sereika SM. Medication adherence in person with cardiovascular disease. J Cardiovasc Nurs. 2003;3:209-218.
12. Apter AJ, Boston RC, George M, et al. Modifiable barriers to adherence to inhaled steroids among adults with asthma: It's not just black and white. J Allergy Clin Immunol. 2003;111:1219-1226. (Pubitemid 36683673)
13. Silberstein SD, for the US Headache Consortium. 2000 Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. http://www.neurology.org/content/55/6/754.full.pdf+html.
14. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention a randomized controlled trial. JAMA. 2004;8:965-973. (Pubitemid 38543754)
15. Zissis NP, Harmoussi S, Vlaikidis N, Thomaidis T, Georgiadis G, Karageorgiou K. A randomized, double-blind, placebo-controlled study of venlafaxine xr in out-patients with tension-type headache. Cephalalgia. 2007;27:315-323.
16. D'Amico D, Solari A, Usai S, Santoro P, Bernardoni P, Frediani F. Improvement in quality of life and activity limitations in migraine after prophylaxis: A prospective longitudinal multicenter study. Cephalalgia. 2006;26:691-696.
17. Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache. 2005;45:144-152. (Pubitemid 40315784)
18. Bendsten L, Rigmore Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology. 2004;62:1706-1711.
19. Packard RC, O'Connell P. Medication compliance among headache patients. Headache. 1986;26:416-419.
20. Steiner TJ, Catarci T, Hering R, Whirmarsh T, Couturier EGM. If migraine prophylaxis does not work, think about compliance. Cephalalgia. 1994; 14:463-464. (Pubitemid 24381764)
21. Mullerners WM, Whitemarsh TE, Steiner TJ. Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia. 1998;18:52-56. (Pubitemid 28096519)
22. Dirmaier J, Watzke B, Och U, Lehnert H, Pieper L, Wittchen HU. Diabetes in primary care: Prospective associations between depression, nonadherence, and glycemic control. Psychother Psychosom. 2010;79:172-178.
23. Fisher L, Glasgow RE, Stryker LA. The relationship between diabetes distress and clinical depression with glycemic control among patients with Type 2 diabetes. Diabetes Care. 2010;33:1034-1036. Epub 2010 Feb 11.
24. Park J, Nachman S. The link between religion and HAART adherence in pediatric HIV patients.AIDS Care. 2010;15:1-6.
25. Cha E, Erlen JA, Kim KH, Sereika SM, Caruthers D. Mediating roles of medication-taking self-efficacy and depressive symptoms on self-reported medication adherence in persons with HIV: A questionnaire study. Int J Nurs Stud. 2008;45:1175-1184.
26. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headaches in a population sample. Headache. 1998;38:497-506. (Pubitemid 28429337)
27. Weng FL, Israni AK, Marshall MJ, et al. Race and electronically measured adherence to immunosuppressive medication after deceased donor renal transplantation. J Am Soc Nephrol. 2005;16:1839-1848. (Pubitemid 41716492)
28. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17:756-765. (Pubitemid 35286241)
29. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentration in patients on multidrug, antiretroviral regimens. JAIDS. 2002;23:386-395.
30. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees:The roles of age gender, and race. Am J Public Health. 1996;86:1805-1808.
31. Heckman BD, Holroyd KA, Tietjen G, et al.Whites and African American in specialty clinic respond equally well to treatment. Cephalalgia. 2009;2:650-661.
32. Heckman BD, Catz S, Heckman TG, Miller JG, Kalichman SC. Adherence to antiretroviral therapies among HIV-infected rural persons. AIDS Care. 2004;16:219-230. (Pubitemid 38183585)
33. Jayawant SS, Feldman SR, Camacho FT, Yentzer B, Balkrishnan R. Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea. J Dermatolog Treat. 2008;19:267-273.
34. Wu J, Lennie TA, Jong MJ, et al. Medication adherence is a mediator of the relationship between ethnicity and event-free survival in patients with heart failure. J Card Fail. 2010;16:142-149.
35. Gellad WF, Haas JS, Safran DG. Race-ethnicity and nonadherence to prescription medications among seniors: Results of a national study. J Gen Intern Med. 2007;22:1572-1578. (Pubitemid 47568699)
36. Fleck DE, Keck PE, Corey KB, Strakowski SM. Factors associated with medication adherence in African American and white patients with bipolar disorder. J Clin Psychiatry. 2005;66:646-652. (Pubitemid 40733710)
37. Bogart LM, Howerton D, Lange J, et al. Provider-related barriers to rapid HIV testing in US urban non-profit community clinics, community-based organizations (CBOs) and hospitals. AIDS Behav. 2010;14:697-707.
38. Anderson ES, Winett RA, Wojcik JR. Self-regulation, self-efficacy, outcome expectations, and social support: Social cognitive theory and nutrition behavior. Ann Behav Med. 2007;34:304-312. (Pubitemid 350276272)
39. Anderson ES, Winett RA, Wojcik JR, Williams DM. Social cognitive mediators of change in a group randomized nutrition and physical activity intervention: Social support, self-efficacy, outcome expectations, and self regulation in the guide-to-health trial. J Health Psychol. 2010;15:21-32.
40. Ayotte BJ, Margrett JA, Hick-Patrick J. Physical activity in middle-aged and young-old adults: The roles of self-efficacy barriers, outcome expectancies, self-regulatory behaviors and social support. J Health Psychol. 2010;15:173-185.
41. Blamey R, Jolly K, Greenfield S, Jobanputra P. Patterns of analgesic use, pain and self-efficacy: A cross-sectional study of patients attending a hospital rheumatology clinic. BMC Musculoskelet Disord. 2009;10:120-137.
42. Cook PF, Emiliozzi S, El-Hajj D, McCabe MM.Telephone nurse counseling for medication adherence in ulcerative colitis:A preliminary study. Patient Educ Couns. 2010;81:182-186. Epub 2010 Jan 15.
43. Liang SY, Yates P, Edwards H, Tsay SL. Factors influencing opioid-taking self-efficacy and analgesic adherence in Taiwanese outpatients with cancer. Psychooncology. 2008;21:1100-1107.
44. Mak WW, Law RW, Woo J, Cheung FM, Lee D. Social support and psychological adjustments to SARS: The mediating role of self-care self-efficacy. Psychol Health. 2009;24:161-174.
45. Safren SA, Traeger L, Skeer MR, et al. Testing a social-cognitive model of HIV transmission risk behaviors in HIV-infected MSM with and without depression. Health Psychol. 2010;29:215-221.
46. Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25:74-81. (Pubitemid 43214384)
47. Bandura A. Self-efficacy. In: Ramachaudran VS, ed. Encyclopedia of Human Behavior. Vol. 4. 71-81. New York: Academic Press; 1994.
48. Sheffield D, Biles PL, Maixner W, Sheps DS. Race and sex differences in cutaneous pain perception. Psychosom Med. 2000;62:517-523. (Pubitemid 30604796)
49. Riley JL, Wade JB, Myers CD, Sheffield D, Papas RK, Price DD. Racial differences in the experience of chronic pain. Pain. 2002;100:291-298.
50. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia. 2004;24:1-160.
51. Heckman BD, Holroyd KA, O'Donnell FJ, et al. Race differences in adherence to headache treatment appointments in persons with headache disorders. J Natl Med Assoc. 2008;100:243-247.
52. Heckman BD, Holroyd KA, O'Donnell FJ, Tietjen G, Utley C, Stillman M. Do psychiatric comorbidities influence headache treatment effectiveness? Results of a naturalistic longitudinal treatment study? Pain. 2000;146:56-64.
53. Heckman BD, Berlin K, Watakakosol R, Pierre V. Psychometric characteristics and measurement invariance of psychosocial headache measures in Caucasian and African American headache patients. Cephalalgia. 2010;29:650-651.
54. Spitzer R, Williams J, Kroenke K.Validity and utility of the PRIME-MD Patient Health Questionnaire in assessment of 3,000 obstetric-gynecologic patients: The PRIME-MD patient health questionnaire obstetrics-gynecology study. Am J Obstet Gynecol. 2000;183:759-769.
55. French DJ, Holroyd KA, Cornelia P, Malinoski PT, O'Donnell F, Hill KR. Perceived self-efficacy and headache related disability. Headache. 2000;40:647-656.
56. Beck A. Cognitive Therapy and the Emotional Disorders. New York: Penguin; 1993.
57. Safren SA, O'Clerigh C, Tan JY, et al.A randomised controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1-10.
58. Weissman MM, Markowitz JC, Klerman G. Clinican's Quick Guide to Interpersonal Psychotherapy. New York: Oxford University Press; 2007.